Page last updated: 2024-08-24

plerixafor and Overweight

plerixafor has been researched along with Overweight in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gardellini, A; Lanza, F; Laszlo, D; Martino, M1
Apperley, JF; Basak, GW; Douglas, KW; Duarte, RF; Gabriel, IH; Geraldes, C; Hübel, K; Jaksic, O; Koristek, Z; Lanza, F; Lemoli, R; Mikala, G; Mohty, M; Selleslag, D; Wiktor-Jedrzejczak, W; Worel, N1

Other Studies

2 other study(ies) available for plerixafor and Overweight

ArticleYear
Plerixafor: what we still have to learn.
    Expert opinion on biological therapy, 2015, Volume: 15, Issue:2

    Topics: Benzylamines; Cyclams; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Lymphoma, Non-Hodgkin; Multiple Myeloma; Obesity; Overweight; Patient Selection; Transplantation, Autologous

2015
Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF.
    Bone marrow transplantation, 2012, Volume: 47, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Benzylamines; Body Mass Index; Contraindications; Cyclams; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Obesity; Overweight; Retrospective Studies; Thinness; Young Adult

2012